Thermo Fisher Scientific (TMO) Announces Exercise of Over-Allotment Option in Common Stock Offering
6/11/2013 10:01:01 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO) (“Thermo Fisher” or the “company”) today announced that the underwriters of its previously announced public offering of common stock have exercised their option to purchase an additional 3,859,649 shares of its common stock at $85.50 per share. Thermo Fisher previously entered into forward sale agreements with affiliates of each of J.P. Morgan and Barclays, which affiliates are referred to as the forward counterparties, with respect to the 25,730,994 shares initially offered for sale and has entered into additional forward sale agreements with respect to the 3,859,649 shares deliverable to the underwriters in connection with the exercise of their over-allotment option. As a result, the forward counterparties are expected to borrow from third parties and sell to the public through the underwriters a total of 29,590,643 shares of common stock in the offering.
Help employers find you! Check out all the jobs and post your resume.
comments powered by